Rodríguez-Carrio Javier, Salazar Nuria, Margolles Abelardo, González Sonia, Gueimonde Miguel, de Los Reyes-Gavilán Clara G, Suárez Ana
Department of Microbiology and Biochemistry of Dairy Products, Instituto de Productos Lácteos de Asturias (IPLA-CSIC), Villaviciosa, Asturias, Spain.
Area of Physiology, Department of Functional Biology, University of Oviedo, Oviedo, Asturias, Spain.
Front Immunol. 2017 Jul 24;8:823. doi: 10.3389/fimmu.2017.00823. eCollection 2017.
A growing body of evidence highlights the relevance of free fatty acids (FFA) for human health, and their role in the cross talk between the metabolic status and immune system. Altered serum FFA profiles are related to several metabolic conditions, although the underlying mechanisms remain unclear. Recent studies have highlighted the link between gut microbiota and host metabolism. However, although most of the studies have focused on different clinical conditions, evidence on the role of these mediators in healthy populations is lacking. Therefore, we have addressed the analysis of the relationship among gut microbial populations, short-chain fatty acid (SCFA) production, FFA levels, and immune mediators (IFNγ, IL-6, and MCP-1) in 101 human adults from the general Spanish population. Levels of selected microbial groups, representing the major phylogenetic types present in the human intestinal microbiota, were determined by quantitative PCR. Our results showed that the intestinal abundance of was the main predictor of total FFA serum levels, displaying a negative association with total FFA and the pro-inflammatory cytokine IL-6. Similarly, an altered FFA profile, identified by cluster analysis, was related to imbalanced levels of and as well as increased fecal SCFA, enhanced IL-6 serum levels, and higher prevalence of subclinical metabolic alterations. Although no differences in nutritional intakes were observed, divergent patterns in the associations between nutrient intakes with intestinal microbial populations and SCFA were denoted. Overall, these findings provide new insights on the gut microbiota-host lipid metabolism axis and its potential relevance for human health, where FFA and SCFA seem to play an important role.
越来越多的证据凸显了游离脂肪酸(FFA)对人类健康的相关性及其在代谢状态与免疫系统相互作用中的作用。血清FFA谱的改变与多种代谢状况相关,但其潜在机制仍不清楚。最近的研究强调了肠道微生物群与宿主代谢之间的联系。然而,尽管大多数研究集中在不同的临床状况上,但缺乏关于这些介质在健康人群中作用的证据。因此,我们对来自西班牙普通人群的101名成年人的肠道微生物群、短链脂肪酸(SCFA)产生、FFA水平和免疫介质(IFNγ、IL-6和MCP-1)之间的关系进行了分析。通过定量PCR测定了代表人类肠道微生物群中主要系统发育类型的选定微生物群的水平。我们的结果表明,[具体微生物名称]的肠道丰度是总FFA血清水平的主要预测指标,与总FFA和促炎细胞因子IL-6呈负相关。同样,通过聚类分析确定的FFA谱改变与[具体微生物名称]和[具体微生物名称]水平失衡、粪便SCFA增加、IL-6血清水平升高以及亚临床代谢改变的较高患病率相关。尽管未观察到营养摄入方面的差异,但营养摄入与肠道微生物群和SCFA之间的关联存在不同模式。总体而言,这些发现为肠道微生物群-宿主脂质代谢轴及其对人类健康的潜在相关性提供了新的见解,其中FFA和SCFA似乎起着重要作用。